Work

FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION BEZAFIBRATE FAST DISSOLVING TABLETSg[p[pv

Year: 2026

Type: article

Abstract: This study aimed to formulate, develop, and evaluate fast-dissolving tablets of bezafibrate using the solid dispersion method. The formulation process focused on enhancing the dissolution rate and bioavailability of bezafibrate, a poorly water-soluble drug. Precompression parameters such as thickness, diameter, hardness, friability, drug content, and weight variation were optimized to ensure the quality and uniformity of the tablets. In vitro evaluation involved assessing dispersion time, wetting time, and dissolution profiles over a three-month period to determine stability under different storage conditions. The findings suggest that the developed bezafibrate fast-dissolving tablets hold promise for improved drug delivery and patient compliance, offering valuable insights into their formulation and performance.

Source: World Journal of Pharmaceutical Research

DOI: 10.5281/zenodo.19627462

Author: Dr. P. Perumal, S. Selvaraj*, K. Manimekala

Language: English

Topic: Drug Solubulity and Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7154682030

FWCI:

Cites:

Cited by:

Related to: